FDA Pinpoints Culprit In Bad Heparin
This article was originally published in The Pink Sheet Daily
Executive Summary
Over-sulfated chondroitin sulfate named as adverse-events link, but China disagrees.
You may also be interested in...
FDA Cracks Down On Unregistered Foreign Pharmaceutical Manufacturers
The agency has sent 11 warning letters for failure to register and list as importers of drugs into the U.S. since the beginning of the year.
FDA’s Poor Performance “Invites Catastrophe,” House Investigator Says
Good public health response, poor regulatory oversight mark adulterated heparin episode, Nelson testifies.
FDA’s Poor Performance “Invites Catastrophe,” House Investigator Says
Good public health response, poor regulatory oversight mark adulterated heparin episode, Nelson testifies.